Product Information

TEMAZEPAM 15 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $0.0729 per EA under NDC 00406996101. Its NADAC has been published 336 times since Jun 10, 2020.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TEMAZEPAM 15 MG CAPSULE

temazepam
$0.0729per EA
High Outlier
DEA Schedule CIV

Strength

15 mg/1

Manufacturer

SpecGx LLC

NDC

00406996101

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TEMAZEPAM

Approval Type

New Drug (NDA)

FDA Application

NDA018163

FDA Approved

Before 1982

TE Code

AB

On Market Since

2/23/2010

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for TEMAZEPAM 15 MG CAPSULE has been published 336 times since Jun 10, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0729 per EA
All-time high$0.0822 (May 11, 2022)
All-time low$0.0548 (Nov 20, 2024)
52-week high$0.0793
52-week low$0.0729
Median price$0.0771
Average price$0.0753
Largest weekly change-29.8% (Nov 20, 2024)
Weeks tracked336
Tracking sinceJun 10, 2020

Price History

1W

0.0%

1M

-4.9%

3M

-8.1%

6M

-8.0%

1Y

-3.5%

3Y

-0.2%

5Y

+1.8%

All

-2.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TEMAZEPAM 15 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 15 MG CAPSULE, manufactured by SpecGx LLC, is $0.0729 per EA (NDC 00406996101), effective Nov 11, 2026.

How has the price of TEMAZEPAM 15 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TEMAZEPAM 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 336 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for TEMAZEPAM 15 MG CAPSULE?

Since Jun 10, 2020, the NADAC for TEMAZEPAM 15 MG CAPSULE has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0822 (May 11, 2022), with a median of $0.0771 per EA.

Are there cheaper alternatives to TEMAZEPAM 15 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TEMAZEPAM 15 MG CAPSULE?

TEMAZEPAM 15 MG CAPSULE (NDC 00406996101) is labeled by SpecGx LLC, and CMS classifies it as a generic product.